Preliminary study of pulsed-electromagnetic fields effects on endothelial (HUVEC) cell secretions--modulation of the thrombo-hemorrhagic balance.

Electromagnetic biology and medicine · 2008 · Mixed · Very low evidence

← Research stream
MixedVery low evidencePaper 4989

Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors rep…

Study snapshot

PublicationElectromagnetic biology and medicine · 2008
Study typein_vitro
Reported directionMixed
Evidence ratingVery low

Abstract

We investigated the role of low-amplitude magnetic pulse with low repetition frequency superimposed on the environmental electromagnetic field (EMF) on the secretion of anti-aggregant (Prostacyclin or PGI(2)) and pro-aggregant (Thromboxane A(2)) agents in endothelial cells of the human umbilical cord vein (HUVEC). We established that magnetic pulse exposure modulates both PGI(2) and TXA(2). These modulations depend on the frequency, width of the pulse, and intensity of the magnetic field. Moreover, we corroborated previous results obtained with an endothelial cell line (EaHy-926), concerning the increased thrombo-embolic risk for the 1 Hz frequency.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typein_vitro
Effect directionmixed
PopulationHuman umbilical cord vein endothelial cells (HUVEC)
Sample sizeNot supplied
ExposureNot supplied
Evidence strengthVery lowConfidence: 74% · Peer reviewed: yes

Main findings

Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.

Outcomes measured

  • Secretion/modulation of prostacyclin (PGI2)
  • Secretion/modulation of thromboxane A2 (TXA2)
  • Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)

Limitations

  • In vitro cell model; findings may not translate to humans
  • Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)
  • Sample size and statistical details not reported in abstract
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": null,
    "source": "pulsed magnetic field superimposed on environmental EMF",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Human umbilical cord vein endothelial cells (HUVEC)",
  "sample_size": null,
  "outcomes": [
    "Secretion/modulation of prostacyclin (PGI2)",
    "Secretion/modulation of thromboxane A2 (TXA2)",
    "Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)"
  ],
  "main_findings": "Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.",
  "effect_direction": "mixed",
  "limitations": [
    "In vitro cell model; findings may not translate to humans",
    "Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)",
    "Sample size and statistical details not reported in abstract"
  ],
  "evidence_strength": "very_low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "pulsed electromagnetic fields",
    "magnetic pulse",
    "environmental EMF",
    "HUVEC",
    "endothelial cells",
    "prostacyclin",
    "PGI2",
    "thromboxane A2",
    "TXA2",
    "platelet aggregation",
    "thrombo-hemorrhagic balance",
    "thrombo-embolic risk",
    "1 Hz"
  ],
  "suggested_hubs": [
    {
      "slug": "elf-emf",
      "weight": 0.6,
      "reason": "Low repetition frequency (e.g., 1 Hz) pulsed magnetic field exposure."
    },
    {
      "slug": "mechanisms-in-vitro",
      "weight": 0.85,
      "reason": "In vitro endothelial cell secretion changes (PGI2/TXA2) under pulsed magnetic field exposure."
    }
  ]
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1080/15368370802414145
PubMed: 19037787

Read the original paper →

Related papers

← Back to the Research Library